Wuliang Wang
Impact in
- Obstetrics and Gynecology top 10%
- Endometrial and Cervical Cancer Treatments
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Endometrial and Cervical Cancer Treatments 10
-
- Epigenetics and DNA Methylation 3
- Circular RNAs in diseases 2
- Co-authors
- Yuling Liu (2 shared papers)Hu Zhao (4 shared papers)Jia Liu (1 shared paper)Chenyang Wang (1 shared paper)Xiaoqin Lu (5 shared papers)Chunlin Chen (7 shared papers)Ping Liu (7 shared papers)Min Xu (1 shared paper)
In The Last Decade
Wuliang Wang
24 papers receiving 207 citations
Peers
Comparison fields: 5 of 51
- Obstetrics and Gynecology 58
- Cancer Research 47
- Reproductive Medicine 26
- Biological Psychiatry 5
- Oncology 33
Countries citing papers authored by Wuliang Wang
This map shows the geographic impact of Wuliang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wuliang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wuliang Wang more than expected).
Fields of papers citing papers by Wuliang Wang
This network shows the impact of papers produced by Wuliang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wuliang Wang. The network helps show where Wuliang Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Wuliang Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 34 | |
| 2 | 2016 | 27 | |
| 3 | 2022 | 26 | |
| 4 | 2013 | 19 | |
| 5 | 2019 | 15 | |
| 6 | 2018 | 14 | |
| 7 | 2023 | 11 | |
| 8 | 2022 | 8 | |
| 9 | 2022 | 7 | |
| 10 | 2022 | 6 | |
| 11 | 2019 | 6 | |
| 12 | 2023 | 6 | |
| 13 | 2021 | 5 | |
| 14 | 2022 | 5 | |
| 15 | 2021 | 3 | |
| 16 | 2015 | 3 | |
| 17 | 2023 | 2 | |
| 18 | 2025 | 2 | |
| 19 | 2023 | 2 | |
| 20 | 2016 | 2 |
About Wuliang Wang
Wuliang Wang is a scholar working on Obstetrics and Gynecology, Molecular Biology, Oncology, Cancer Research and Reproductive Medicine, having authored 28 papers that have together received 209 indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (10 papers), Cervical Cancer and HPV Research (3 papers), Epigenetics and DNA Methylation (3 papers), Endometriosis Research and Treatment (2 papers), Metabolism and Genetic Disorders (2 papers), Cancer-related Molecular Pathways (2 papers), Circular RNAs in diseases (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Obstetrics and Gynecology (58 citations), Cancer Research (47 citations), Reproductive Medicine (26 citations), Biological Psychiatry (5 citations) and Oncology (33 citations). Wuliang Wang has collaborated with scholars based in China, Japan and Hungary. Frequent co-authors include Yuling Liu, Hu Zhao, Jia Liu, Chenyang Wang, Xiaoqin Lu, Chunlin Chen, Ping Liu, Min Xu, Lu Wang and Xiaonong Bin. Their work appears in journals such as Frontiers in Oncology, Artificial Cells Nanomedicine and Biotechnology, The Oncologist, International Journal of Gynecological Cancer and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.